NL-OMON23956已完成不适用
Protection against chemotherapy induced damage in the digestive tract in childhood cancer patients.
umico Research0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
- Pediatr Blood Cancer. 2007 May;48(5):532-9.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children with ANLL, MDS, B-NHL, infant ALL who will receive 2 or more similar courses of chemotherapy;
- •2. Children diagnosed with other malignancies who receive more than 2 similar courses of chemotherpy and develop mucosal barrier injury during one of the first courses;
排除标准
- •1. Clinical signs of inflammatory bowel disease, coeliac disease or cow's milk protein allergy;
- •2. Radiotheray of the abdomen less than 6 months before TGF-beta2 administration.
研究者
相似试验
已完成
不适用
Protection against chemotherapy induced damage in the digestive tract in childhood cancer patientsISRCTN13358395Danone Research B.V. (The Netherlands)30
已完成
3 期
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid LeukemiaCardiotoxicityAcute Myeloid Leukemia in ChildrenBone TumorNCT03389724Children's Cancer Hospital Egypt 57357245
招募中
不适用
Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions (The CLOCK trial)Paediatric CancerCentral vascular access device (CVAD) related adverse eventsCancer - Any cancerACTRN12622000499785niversity of Queensland720
Unknown
2 期
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain TumorsBrain and Central Nervous System TumorsNeuroblastomaNCT00281905Children's Cancer and Leukaemia Group50
终止
2 期
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood FibrosarcomaSarcomaNCT00072280Children's Oncology Group7